Literature DB >> 20222174

Influence of efflux pump inhibitors on the multidrug resistance of Helicobacter pylori.

Zhan Zhang1, Zhi-Qiang Liu, Peng-Yuan Zheng, Fu-Ai Tang, Ping-Chang Yang.   

Abstract

AIM: To evaluate the effect of efflux pump inhibitors (EPIs) on multidrug resistance of Helicobacter pylori (H. pylori).
METHODS: H. pylori strains were isolated and cultured on Brucella agar plates with 10% sheep's blood. The multidrug resistant (MDR) H. pylori were obtained with the inducer chloramphenicol by repeated doubling of the concentration until no colony was seen, then the susceptibilities of the MDR strains and their parents to 9 antibiotics were assessed with agar dilution tests. The present study included periods before and after the advent of the EPIs, carbonyl cyanide m-chlorophenyl hydrazone (CCCP), reserpine and pantoprazole), and the minimum inhibitory concentrations (MICs) were determined accordingly. In the same way, the effects of 5 proton pump inhibitors (PPIs), used in treatment of H. pylori infection, on MICs of antibiotics were evaluated.
RESULTS: Four strains of MDR H. pylori were induced successfully, and the antibiotic susceptibilities of MDR strains were partly restored by CCCP and pantoprazole, but there was little effect of reserpine. Rabeprazole was the most effective of the 5 PPIs which could decrease the MICs of antibiotics for MDR H. pylori significantly.
CONCLUSION: In vitro, some EPIs can strengthen the activities of different antibiotics which are the putative substrates of the efflux pump system in H. pylori.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20222174      PMCID: PMC2839183          DOI: 10.3748/wjg.v16.i10.1279

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Inhibitors of antibiotic efflux pump in resistant Enterobacter aerogenes strains.

Authors:  Monique Malléa; Jacqueline Chevalier; Annie Eyraud; Jean-Marie Pagès
Journal:  Biochem Biophys Res Commun       Date:  2002-05-24       Impact factor: 3.575

2.  Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro.

Authors:  J E Bina; R A Alm; M Uria-Nickelsen; S R Thomas; T J Trust; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps.

Authors:  Jürgen A Bohnert; Winfried V Kern
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

4.  A MATE family multidrug efflux transporter pumps out fluoroquinolones in Bacteroides thetaiotaomicron.

Authors:  S Miyamae; O Ueda; F Yoshimura; J Hwang; Y Tanaka; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

5.  Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple-antibiotic-resistant Campylobacter jejuni.

Authors:  Lilian Pumbwe; Luke P Randall; Martin J Woodward; Laura J V Piddock
Journal:  J Antimicrob Chemother       Date:  2004-06-16       Impact factor: 5.790

6.  EfrAB, an ABC multidrug efflux pump in Enterococcus faecalis.

Authors:  Eun-Woo Lee; M Nazmul Huda; Teruo Kuroda; Tohru Mizushima; Tomofusa Tsuchiya
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

7.  Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.

Authors:  J R Aeschlimann; L D Dresser; G W Kaatz; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

Review 8.  ABC transporters as potential targets for modulation of drug resistance.

Authors:  L Gatti; G L Beretta; G Cossa; F Zunino; P Perego
Journal:  Mini Rev Med Chem       Date:  2009-08       Impact factor: 3.862

9.  Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany.

Authors:  Nicole Wueppenhorst; Hans-Peter Stueger; Manfred Kist; Erik Glocker
Journal:  J Antimicrob Chemother       Date:  2009-02-03       Impact factor: 5.790

10.  Inhibitors of antibiotic efflux in resistant Enterobacter aerogenes and Klebsiella pneumoniae strains.

Authors:  Jacqueline Chevalier; Jérôme Bredin; Abdallah Mahamoud; Monique Malléa; Jacques Barbe; Jean-Marie Pagès
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

View more
  27 in total

1.  Occurrence of Mutations in the Antimicrobial Target Genes Related to Levofloxacin, Clarithromycin, and Amoxicillin Resistance in Helicobacter pylori Isolates from Buenos Aires City.

Authors:  Gerardo Zerbetto De Palma; Nicolas Mendiondo; Andrés Wonaga; Luis Viola; Daniela Ibarra; Esteban Campitelli; Nicolas Salim; Rodolfo Corti; Cinthia Goldman; Mariana Catalano
Journal:  Microb Drug Resist       Date:  2016-07-08       Impact factor: 3.431

2.  Inhibitory effects of emodin, baicalin, schizandrin and berberine on hefA gene: treatment of Helicobacter pylori-induced multidrug resistance.

Authors:  Yan-Qiang Huang; Gan-Rong Huang; Ming-Hui Wu; Hua-Ying Tang; Zan-Song Huang; Xi-Han Zhou; Wen-Qiang Yu; Jian-Wei Su; Xiao-Qiang Mo; Bing-Pu Chen; Li-Juan Zhao; Xiao-Feng Huang; Hong-Yu Wei; Lian-Deng Wei
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

3.  Mechanisms of Helicobacter pylori antibiotic resistance: An updated appraisal.

Authors:  Vincenzo De Francesco; Angelo Zullo; Cesare Hassan; Floriana Giorgio; Rosa Rosania; Enzo Ierardi
Journal:  World J Gastrointest Pathophysiol       Date:  2011-06-15

Review 4.  Microbial efflux pump inhibition: tactics and strategies.

Authors:  George P Tegos; Mark Haynes; J Jacob Strouse; Mohiuddin Md T Khan; Cristian G Bologa; Tudor I Oprea; Larry A Sklar
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 5.  High antibiotic resistance rate: A difficult issue for Helicobacter pylori eradication treatment.

Authors:  Mei Zhang
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

6.  High Efficacy of Finafloxacin on Helicobacter pylori Isolates at pH 5.0 Compared with That of Other Fluoroquinolones.

Authors:  Jung Won Lee; Nayoung Kim; Ryoung Hee Nam; Jung Mogg Kim; Jong Youn Park; Sun Min Lee; Joo Sung Kim; Dong Ho Lee; Hyun Chae Jung
Journal:  Antimicrob Agents Chemother       Date:  2015-09-28       Impact factor: 5.191

Review 7.  Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications.

Authors:  Evariste Tshibangu-Kabamba; Yoshio Yamaoka
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-17       Impact factor: 46.802

8.  Sensitization of Staphylococcus aureus to methicillin and other antibiotics in vitro and in vivo in the presence of HAMLET.

Authors:  Laura R Marks; Emily A Clementi; Anders P Hakansson
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

9.  Anti-Helicobacter pylori effects of IgY from egg york of immunized hens.

Authors:  Yun-Hui Yang; Dongsun Park; Goeun Yang; Sun Hee Lee; Dae Kwon Bae; Jangbeen Kyung; Dajeong Kim; Ehn-Kyoung Choi; Jae-Cheol Son; Seock-Yeon Hwang; Yun-Bae Kim
Journal:  Lab Anim Res       Date:  2012-03-21

10.  In vitro and in vivo anti-Helicobacter pylori activities of FEMY-R7 composed of fucoidan and evening primrose extract.

Authors:  Jingmei Cai; Tae-Su Kim; Ja Young Jang; Jihyun Kim; Kyungha Shin; Sung-Pyo Lee; Ehn-Kyoung Choi; Sa-Hyun Kim; Min Park; Jong Bae Kim; Yun-Bae Kim
Journal:  Lab Anim Res       Date:  2014-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.